Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             31 results found
no title author magazine year volume issue page(s) type
1 Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles Peetla, Chiranjeevi
 2013
 151-152 13-14 p. 1686-1698
13 p.
 article
2 Can nanomedicines kill cancer stem cells? Zhao, Yi
 2013
 151-152 13-14 p. 1763-1783
21 p.
 article
3 Clinical implications of mitochondrial disease Muravchick, Stanley
 2008
 151-152 13-14 p. 1553-1560
8 p.
 article
4 Editorial Board 2013
 151-152 13-14 p. ii-
1 p.
 article
5 Editorial Board 2008
 151-152 13-14 p. ii-
1 p.
 article
6 Estrogen regulation of glucose metabolism and mitochondrial function: Therapeutic implications for prevention of Alzheimer's disease Brinton, Roberta Diaz
 2008
 151-152 13-14 p. 1504-1511
8 p.
 article
7 Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities Kirtane, Ameya R.
 2013
 151-152 13-14 p. 1731-1747
17 p.
 article
8 Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease Maczurek, Annette
 2008
 151-152 13-14 p. 1463-1470
8 p.
 article
9 Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases Yamada, Yuma
 2008
 151-152 13-14 p. 1439-1462
24 p.
 article
10 Mitochondrial-mediated suppression of ROS production upon exposure of neurons to lethal stress: Mitochondrial targeted preconditioning Busija, David W.
 2008
 151-152 13-14 p. 1471-1477
7 p.
 article
11 Mitochondrial medicine and mitochondrion-based therapeutics Hamm-Alvarez, Sarah
 2008
 151-152 13-14 p. 1437-1438
2 p.
 article
12 Mitochondrial nitric oxide synthase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants Navarro, Ana
 2008
 151-152 13-14 p. 1534-1544
11 p.
 article
13 Mitochondrial trifunctional protein defects: Clinical implications and therapeutic approaches Rector, R. Scott
 2008
 151-152 13-14 p. 1488-1496
9 p.
 article
14 Monitoring oxidative and nitrative modification of cellular proteins; a paradigm for identifying key disease related markers of oxidative stress Murray, James
 2008
 151-152 13-14 p. 1497-1503
7 p.
 article
15 Monoamine oxidase inactivation: From pathophysiology to therapeutics Bortolato, Marco
 2008
 151-152 13-14 p. 1527-1533
7 p.
 article
16 Multidrug resistance: Physiological principles and nanomedical solutions Kunjachan, Sijumon
 2013
 151-152 13-14 p. 1852-1865
14 p.
 article
17 Nanocarriers for delivery of platinum anticancer drugs Oberoi, Hardeep S.
 2013
 151-152 13-14 p. 1667-1685
19 p.
 article
18 Nanomedicine therapeutic approaches to overcome cancer drug resistance Markman, Janet L.
 2013
 151-152 13-14 p. 1866-1879
14 p.
 article
19 Nanopreparations to overcome multidrug resistance in cancer Patel, Niravkumar R.
 2013
 151-152 13-14 p. 1748-1762
15 p.
 article
20 Nanotechnology and drug resistance Minko, Tamara
 2013
 151-152 13-14 p. 1665-1666
2 p.
 article
21 Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases Andrade, Fernanda
 2013
 151-152 13-14 p. 1816-1827
12 p.
 article
22 Nanotechnology approaches for personalized treatment of multidrug resistant cancers Minko, Tamara
 2013
 151-152 13-14 p. 1880-1895
16 p.
 article
23 Nanotechnology as a therapeutic tool to combat microbial resistance Pelgrift, Robert Y.
 2013
 151-152 13-14 p. 1803-1815
13 p.
 article
24 Pathophysiological and pharmacological implications of mitochondria-targeted reactive oxygen species generation in astrocytes Jou, Mei-Jie
 2008
 151-152 13-14 p. 1512-1526
15 p.
 article
25 Pro-oxidant shift in glutathione redox state during aging Rebrin, Igor
 2008
 151-152 13-14 p. 1545-1552
8 p.
 article
26 Rationally designed nanovehicles to overcome cancer chemoresistance Livney, Yoav D.
 2013
 151-152 13-14 p. 1716-1730
15 p.
 article
27 Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor Yin, Qi
 2013
 151-152 13-14 p. 1699-1715
17 p.
 article
28 Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing “Generally Recognized As Safe” (GRAS) nanopharmaceuticals: A review Sosnik, Alejandro
 2013
 151-152 13-14 p. 1828-1851
24 p.
 article
29 Role of dichloroacetate in the treatment of genetic mitochondrial diseases Stacpoole, Peter W.
 2008
 151-152 13-14 p. 1478-1487
10 p.
 article
30 Role of integrated cancer nanomedicine in overcoming drug resistance Iyer, Arun K.
 2013
 151-152 13-14 p. 1784-1802
19 p.
 article
31 The mitochondrial cocktail: Rationale for combined nutraceutical therapy in mitochondrial cytopathies Tarnopolsky, M.A.
 2008
 151-152 13-14 p. 1561-1567
7 p.
 article
                             31 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands